Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
Alfred Lane, Stanford University
ClinicalTrials.gov Identifier:
NCT01454687
First received: October 13, 2011
Last updated: April 10, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)